Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia
Standard
Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia. / Löbel, U; Trah, J; Escherich, G.
in: PEDIATR BLOOD CANCER, Jahrgang 62, Nr. 3, 03.2015, S. 539-41.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia
AU - Löbel, U
AU - Trah, J
AU - Escherich, G
N1 - © 2014 Wiley Periodicals, Inc.
PY - 2015/3
Y1 - 2015/3
N2 - Systemic and intrathecal methotrexate is widely used in treatment protocols for childhood acute lymphoblastic leukemia. Its side effects vary in characteristics, intensity and time of onset, and depend on the administration route. Interactions with several drugs are known. Side effects of nitrous oxide sedation, often used for moderately painful procedures, typically occur after long time use and include neurological symptoms. We present a child who experienced a severe and long-lasting neurotoxicity after the third intrathecal application of methotrexate with short sedation by nitrous oxide during induction therapy for acute lymphoblastic leukemia. Symptoms completely resolved after 12 months.
AB - Systemic and intrathecal methotrexate is widely used in treatment protocols for childhood acute lymphoblastic leukemia. Its side effects vary in characteristics, intensity and time of onset, and depend on the administration route. Interactions with several drugs are known. Side effects of nitrous oxide sedation, often used for moderately painful procedures, typically occur after long time use and include neurological symptoms. We present a child who experienced a severe and long-lasting neurotoxicity after the third intrathecal application of methotrexate with short sedation by nitrous oxide during induction therapy for acute lymphoblastic leukemia. Symptoms completely resolved after 12 months.
KW - Analgesics, Non-Narcotic
KW - Child
KW - Female
KW - Humans
KW - Immunosuppressive Agents
KW - Injections, Spinal
KW - Intracranial Hemorrhages
KW - Methotrexate
KW - Neurotoxicity Syndromes
KW - Nitrous Oxide
KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma
U2 - 10.1002/pbc.25270
DO - 10.1002/pbc.25270
M3 - SCORING: Journal article
C2 - 25360802
VL - 62
SP - 539
EP - 541
JO - PEDIATR BLOOD CANCER
JF - PEDIATR BLOOD CANCER
SN - 1545-5009
IS - 3
ER -